Note: This document contains side effect information about polyethylene glycol 3350 with electrolytes. Some of the dosage forms listed on this page may not apply to the brand name GaviLyte-G.
Applies to polyethylene glycol 3350 with electrolytes: oral powder for solution
Along with its needed effects, polyethylene glycol 3350 with electrolytes (the active ingredient contained in GaviLyte-G) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor immediately if any of the following side effects occur while taking polyethylene glycol 3350 with electrolytes:
Incidence not known
Some side effects of polyethylene glycol 3350 with electrolytes may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
Applies to polyethylene glycol 3350 with electrolytes: oral kit, oral powder for reconstitution
The most common adverse events were abdominal distension, anal discomfort, thirst, nausea, and abdominal pain. Since diarrhea is considered part of the efficacy of this product, it was not defined as an adverse reaction.
Very common (10% or more): Abdominal distension (59.8%), anal discomfort (52%), nausea (47.3%), abdominal pain (39.1%), vomiting (12.8%)
Common (1% to 10%): Upper abdominal pain, dyspepsia
Frequency not reported: Upper gastrointestinal bleeding from a Mallory-Weiss tear, esophageal perforation, borborygmi, flatulence
Very common (10% or more): Hunger (70.8%)
Common (1% to 10%): Hypokalemia, hyperphosphatemia
Frequency not reported: Electrolyte disturbances, hyperkalemia
Very common (10% or more): Rigors (33.7%), malaise (26.6%)
Frequency not reported: Peripheral edema
Very common (10% or more): Dizziness (18.1%)
Common (1% to 10%): Headache
Very common (10% or more): Sleep disorder (34.9%)
Frequency not reported: Anaphylactic reaction
Postmarketing reports: Hypersensitivity reactions (including anaphylaxis, rash, angioedema, urticaria, lip and facial swelling, dyspnea, chest tightness, throat tightness)
Frequency not reported: Asystole
Frequency not reported: Urticaria, dermatitis
Frequency not reported: Rhinorrhea, acute pulmonary edema, acute pulmonary edema after aspirating the PEG-based preparation
Medically reviewed by BestRx Medical Team Last updated on 1/1/2020.
Source: Drugs.com Gavilyte-g